Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Okuno

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|October 6, 2018
Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cellsDongqing Zuo, Kristen L Shogren, Jie Zang, et al.
Journal of Cutaneous Pathology|November 5, 2011
Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsivenessWonwoo Shon, Sarah M Jenkins, Douglas T Ross, et al.
Anticancer Research|December 31, 2024
Outcomes of Scapular OsteosarcomaLeilani Garayua-Cruz, Samuel E Broida, Steven I Robinson, et al.
Gene|June 23, 2018
Decreased local and systemic levels of sFRP3 protein in osteosarcoma patientsDalibel Bravo, Ahmet Salduz, Kristen L Shogren, et al.
Cancer|December 15, 2004
A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tractRobert L Foote, Jan L Kasperbauer, Scott H Okuno, et al.
American Journal of Clinical Oncology|August 7, 2003
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancerRandolph S Marks, David L Graham, Jeff A Sloan, et al.
Cancers|September 28, 2024
Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and SurvivalSamuel E Broida, Alexandra M Arguello, Mikaela H Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcomaSant P Chawla, Lee D Cranmer, Brian A Van Tine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.
Advances in Radiation Oncology|August 29, 2022
New School Technology Meets Old School Technique: Intensity Modulated Proton Therapy and Laparoscopic Pelvic Sling Facilitate Safe and Efficacious Treatment of Pelvic SarcomaHunter C Gits, Eric J Dozois, Matthew T Houdek, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
Journal of Experimental & Clinical Cancer Research : CR|October 6, 2018
Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cellsDongqing Zuo, Kristen L Shogren, Jie Zang, et al.
Journal of Cutaneous Pathology|November 5, 2011
Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsivenessWonwoo Shon, Sarah M Jenkins, Douglas T Ross, et al.
Anticancer Research|December 31, 2024
Outcomes of Scapular OsteosarcomaLeilani Garayua-Cruz, Samuel E Broida, Steven I Robinson, et al.
Gene|June 23, 2018
Decreased local and systemic levels of sFRP3 protein in osteosarcoma patientsDalibel Bravo, Ahmet Salduz, Kristen L Shogren, et al.
Cancer|December 15, 2004
A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tractRobert L Foote, Jan L Kasperbauer, Scott H Okuno, et al.
American Journal of Clinical Oncology|August 7, 2003
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancerRandolph S Marks, David L Graham, Jeff A Sloan, et al.
Cancers|September 28, 2024
Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and SurvivalSamuel E Broida, Alexandra M Arguello, Mikaela H Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcomaSant P Chawla, Lee D Cranmer, Brian A Van Tine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.
Advances in Radiation Oncology|August 29, 2022
New School Technology Meets Old School Technique: Intensity Modulated Proton Therapy and Laparoscopic Pelvic Sling Facilitate Safe and Efficacious Treatment of Pelvic SarcomaHunter C Gits, Eric J Dozois, Matthew T Houdek, et al.
Pageof 23